Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children

Clinical Endocrinology

Volumn 77, Issue 3, 2012, Pages 416-422

  Olney, Robert C ^a   Permuy, Joseph W ^a   Prickett, Timothy C R ^b   Han, Joan C ^c   Espiner, Eric A ^b  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO NATRIURETIC PEPTIDE TYPE C; BIOLOGICAL MARKER; NATRIURETIC PEPTIDE TYPE C; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADULTHOOD; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CHILDHOOD; FEMALE; GROWTH RATE; HUMAN; INFANCY; MALE; NORMAL HUMAN; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, C-TYPE; PROSPECTIVE STUDIES; PUBERTY; RADIOIMMUNOASSAY; YOUNG ADULT;

EID: 84864996350     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04392.x     Document Type: Article

References (36)

1. Chusho, H., Tamura, N., Ogawa, Y., et al,. (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proceedings of the National Academy of Sciences of the United States of America, 98, 4016-4021.
2. Tamura, N., Doolittle, L.K., Hammer, R.E., et al,. (2004) Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proceedings of the National Academy of Sciences of the United States of America, 101, 17300-17305.
3. Yasoda, A., Komatsu, Y., Chusho, H., et al,. (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nature Medicine, 10, 80-86.
4. Bartels, C.F., Bukulmez, H., Padayatti, P., et al,. (2004) Mutations in the Transmembrane Natriuretic Peptide Receptor NPR-B Impair Skeletal Growth and Cause Acromesomelic Dysplasia, Type Maroteaux. American Journal of Human Genetics, 75, 27-34.
5. Bocciardi, R., Giorda, R., Buttgereit, J., et al,. (2007) Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. Human Mutation, 28, 724-731.
6. Moncla, A., Missirian, C., Cacciagli, P., et al,. (2007) A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype. Human Mutation, 28, 1183-1188.
7. Miura, K., Namba, N., Fujiwara, M., et al,. (2011) A gain-of-function type mutation of the natriuretic peptide receptor B causes acceleration of skeletal growth and osteoporotic change in humans and mice (abstract). Osteoporos International, 22 (suppl. 4), S536.
8. Suda, M., Tanaka, K., Yasoda, A., et al,. (2002) C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line. Journal of Bone and Mineral Metabolism, 20, 136-141.
9. Wu, C., Wu, F., Pan, J., et al,. (2003) Furin-mediated processing of Pro-C-type natriuretic peptide. Journal of Biological Chemistry, 278, 25847-25852.
10. Prickett, T.C., Lynn, A.M., Barrell, G.K., et al,. (2005) Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatric Research, 58, 334-340.
11. Olney, R.C., Prickett, T.C., Yandle, T.G., et al,. (2007) Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone. Journal of Clinical Endocrinology and Metabolism, 92, 4294-4298.
12. Yandle, T.G., Fisher, S., Charles, C., et al,. (1993) The ovine hypothalamus and pituitary have markedly different distribution of C-type natriuretic peptide forms. Peptides, 14, 713-716.
13. Prickett, T.C., Yandle, T.G., Nicholls, M.G., et al,. (2001) Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochemical and Biophysical Research Communications, 286, 513-517.
14. Prickett, T.C., Kaaja, R.J., Nicholls, M.G., et al,. (2004) N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation. Clincal Science (London), 106, 535-540.
15. National Center for Health Statistics (2002) 2000 CDC Growth Charts for the United States: methods and Development. Vital and Health Statistics, 11, 1-203.
16. Department of Nutrition for Health and Development, WHO. (2009) WHO Child Growth Standards: Growth Velocity Based on Weight, Length and Head Circumference: Methods and Development. WHO, Geneva, Switzerland.
17. Tanner, J.M., &, Davies, P.S., (1985) Clinical longitudinal standards for height and height velocity for North American children. Journal of Pediatrics, 107, 317-329.
18. McKusick, V.A., (1972) Heritable Disorders of Connective Tissue. Mosby, St. Louis.
19. Hall, J.G., Allanson, J.E., Gripp, K.W., et al,. (2007) Handbook of Physical Measurements. Oxford University Press, Oxford.
20. Cole, T.J., (1990) The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition, 44, 45-60.
21. Prickett, T.C., Dixon, B., Frampton, C., et al,. (2008) Plasma amino-terminal pro C-type natriuretic Peptide in the neonate: relation to gestational age and postnatal linear growth. Journal of Clinical Endocrinology and Metabolism, 93, 225-232.
22. Berkey, C.S., Dockery, D.W., Wang, X., et al,. (1993) Longitudinal height velocity standards for U.S. adolescents. Statistics in Medecine, 12, 403-414.
23. Tobiume, H., Kanzaki, S., Hida, S., et al,. (1997) Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. Journal of Clinical Endocrinology and Metabolism, 82, 2056-2061.
24. Kanbur, N.O., Derman, O., &, Kinik, E., (2005) The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents. Journal of Bone and Mineral Metabolism, 23, 76-83.
25. Crofton, P.M., Wade, J.C., Taylor, M.R., et al,. (1997) Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren. Clinical Chemistry, 43, 1577-1581.
26. Rauchenzauner, M., Schmid, A., Heinz-Erian, P., et al,. (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. Journal of Clinical Endocrinology and Metabolism, 92, 443-449.
27. Rauch, F., Georg, M., Stabrey, A., et al,. (2002) Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children. Clinical Chemistry, 48, 315-322.
28. Posey, K.L., &, Hecht, J.T., (2008) The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Current Drug Targets, 9, 869-877.
29. Bjarnason, R., Andersson, B., Kim, H.S., et al,. (2004) Cartilage oligomeric matrix protein increases in serum after the start of growth hormone treatment in prepubertal children. Journal of Clinical Endocrinology and Metabolism, 89, 5156-5160.
30. Federico, G., Baroncelli, G.I., Vanacore, T., et al,. (2003) Pubertal changes in biochemical markers of growth. Hormone Research, 60, 46-51.
31. Yasoda, A., Kitamura, H., Fujii, T., et al,. (2009) Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology, 150, 3138-3144.
32. Suda, M., Komatsu, Y., Tanaka, K., et al,. (1999) C-Type natriuretic peptide/guanylate cyclase B system in rat osteogenic ROB-C26 cells and its down-regulation by dexamethazone. Calcified Tissue International, 65, 472-478.
33. Potter, L.R., Abbey-Hosch, S., &, Dickey, D.M., (2006) Natriuretic peptides, their receptors, and cyclic guanosine dependent signaling functions. Endocrine Reviews, 27, 47-72.
34. Palmer, S.C., Prickett, T.C., Espiner, E.A., et al,. (2009) Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension, 54, 612-618.
35. Prickett, T.C., Charles, C.J., Yandle, T.G., et al,. (2011) Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs. Peptides, 30, 2343-2347.
36. Reh, C.S., Olney, R.C., Azen, C., et al,. (2012) Plasma C-type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease. Clinical Endocrinology (Oxford), 76, 228-235.